Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study

Background: Lateral flow immunoassays (LFIAs) are able to achieve affordable, large scale antibody testing and provide rapid results without the support of central laboratories. As part of the development of the REACT programme extensive evaluation of LFIA performance was undertaken with individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Cann, Alexandra, Clarke, Candice, Brown, Jonathan, Thomson, Tina, Prendecki, Maria, Moshe, Maya, Badhan, Anjna, Simmons, Bryony, Klaber, Bob, Elliott, Paul, Darzi, Ara, Riley, Steven, Ashby, Deborah, Martin, Paul, Gleeson, Sarah, Willicombe, Michelle, Kelleher, Peter, Ward, Helen, Barclay, Wendy S., Cooke, Graham S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152464/
https://www.ncbi.nlm.nih.gov/pubmed/35673545
http://dx.doi.org/10.12688/wellcomeopenres.17231.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152464/
https://www.ncbi.nlm.nih.gov/pubmed/35673545
http://dx.doi.org/10.12688/wellcomeopenres.17231.2

Ejemplares similares